Tokio Marine HCC
HCC
$106.73
+3.26%
Warrior Met Coal, Inc. is a leading producer and exporter of metallurgical (steelmaking) coal, operating longwall underground mines in Alabama and supplying steel manufacturers across Europe, South America, and Asia. As a pure-play met coal producer, it holds a distinct position in the seaborne market, with a strong focus on high-quality coal and operational efficiency. The current investor narrative centers on the company's recovery from a challenging 2025, marked by volatile coal prices and operational headwinds, but recent quarterly results show a sharp rebound in revenue and profitability, fueling optimism about a cyclical upswing. Additionally, the stock's significant outperformance versus the broader market over the past year has drawn attention to its leveraged exposure to global steel demand and met coal pricing dynamics.…
HCC
Tokio Marine HCC
$106.73
Investment Opinion: Should I buy HCC Today?
Rating: Buy. The thesis is that HCC is a cyclical recovery play with strong near-term momentum and a low forward PE, offering upside to analyst targets. The consensus is Buy with an average target of $103, implying 14.9% upside.
Sign up to view all
HCC 12-Month Price Forecast
The AI model assesses HCC as a bullish opportunity given the strong revenue rebound, attractive forward valuation, and positive analyst sentiment. The main risks are commodity price volatility and execution on Blue Creek, which could derail the recovery. The stance would be upgraded to high confidence if met coal prices sustain above $200/ton and Blue Creek milestones are met; downgraded to neutral if revenue growth slows below 10% or FCF turns more negative.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Tokio Marine HCC's 12-month outlook, with a consensus price target around $102.67 and implied upside of -3.8% versus the current price.
Average Target
$102.67
0 analysts
Implied Upside
-3.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$90 - $123
Analyst target range
The stock is covered by 6 analysts, with a consensus recommendation of 'Buy' (mean rating of 1.86 on a scale where 1 is Strong Buy and 5 is Sell). The average target price is $103.00, implying an upside of 14.9% from the current price of $89.62. The distribution shows no Sell ratings, with the majority at Buy, indicating a bullish sentiment. The target price range spans from $90.00 (low) to $123.00 (high), representing a wide spread of 36.7% from low to high, which reflects significant uncertainty about the future path of met coal prices and the success of the Blue Creek expansion. The high target of $123 suggests expectations of a strong cyclical recovery and successful execution of growth projects, while the low target of $90 implies a more conservative scenario with potential margin compression or weaker demand. Recent rating actions have been predominantly positive, with UBS upgrading from Neutral to Buy in January 2026, and Citigroup and B. Riley maintaining Buy ratings, indicating growing institutional confidence in the company's prospects.
Bulls vs Bears: HCC Investment Factors
Warrior Met Coal presents a compelling cyclical recovery story, with strong Q4 revenue growth, high margins, and a low forward PE. The bull case is supported by analyst optimism and a solid balance sheet, while the bear case highlights negative FCF, earnings volatility, and commodity price risk. Currently, the bull case has stronger evidence given the sharp earnings rebound and attractive forward valuation, but the key tension is whether the Blue Creek investment will generate the expected returns and whether met coal prices can sustain the recovery. If prices hold and the project executes well, the stock has significant upside; if not, the high trailing PE and cash burn could lead to downside.
Bullish
- Strong Revenue Rebound: Q4 2025 revenue surged 29.1% YoY to $384.0M, following a weak Q1, indicating accelerating demand and pricing power in met coal markets. This recovery is a key driver of the positive earnings trajectory.
- High Gross Margin: Gross margin reached 98.9% in Q4 2025, reflecting extremely low cost of revenue ($4.0M) due to accounting adjustments, but even normalized, the product is highly profitable. This demonstrates the company's ability to capture value from high-quality coal.
- Attractive Forward Valuation: Forward PE of 12.3x is well below the S&P 500's ~20x, suggesting the market is pricing in a cyclical recovery. If earnings normalize as analysts expect (EPS estimate $8.94), the stock offers significant upside.
- Analyst Consensus Buy: With a mean rating of 1.86 (Buy) and average target of $103.00, analysts see 14.9% upside. No Sell ratings and recent upgrades (e.g., UBS to Buy) indicate growing institutional confidence.
Bearish
- Negative Free Cash Flow: TTM free cash flow is -$111.2M due to heavy capex ($94.2M in Q4 alone) for Blue Creek. This cash burn could pressure liquidity if coal prices weaken or project costs overrun.
- Cyclical Earnings Volatility: Net income swung from a -$8.2M loss in Q1 2025 to $23.0M profit in Q4, illustrating extreme sensitivity to met coal prices. Such volatility makes earnings unpredictable and can lead to sharp stock swings.
- High Trailing PE: Trailing PE of 81.6x is elevated due to depressed TTM EPS ($0.0123). If the expected earnings recovery falters, the stock could be vulnerable to de-rating.
- Commodity Price Risk: As a pure-play met coal producer, HCC's fortunes are tied to global steel demand and coal prices. Any downturn in China's economy or shift to greener steelmaking could compress margins and revenue.
HCC Technical Analysis
Warrior Met Coal's stock is in a clear long-term uptrend, with a 1-year price change of +63.4%, significantly outpacing the S&P 500's +21.5% over the same period. The current price of $89.62 sits at 81.2% of its 52-week range (between $54.66 low and $110.39 high), indicating the stock is trading near the upper end of its yearly range, which typically reflects strong momentum and investor confidence. However, the stock is still about 18.8% below its 52-week high, suggesting some room before reaching prior peaks, and the recent pullback from the June high of $110.28 to the July low of $77.74 highlights the volatility inherent in this commodity-linked equity.
Beta
0.65
0.65x market volatility
Max Drawdown
-29.5%
Largest decline past year
52-Week Range
$55-$110
Price range past year
Annual Return
+86.6%
Cumulative gain past year
| Period | HCC Return | S&P 500 |
|---|---|---|
| 1m | +28.4% | +2.5% |
| 3m | +27.2% | +2.7% |
| 6m | +25.5% | +11.1% |
| 1y | +86.6% | +20.5% |
| ytd | +19.2% | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HCC Fundamental Analysis
Revenue has shown a strong recovery, with the most recent quarter (Q4 2025) reporting $384.0 million, up 29.1% year-over-year, and a sequential increase from $297.5 million in Q2 2025. This rebound follows a weak Q1 2025 where revenue was $299.9 million, and the trend indicates accelerating growth, driven by higher met coal prices and volumes. The company's gross margin in Q4 2025 was an impressive 98.9%, though this is partly due to accounting adjustments; the more normalized gross margin (excluding cost of revenue of $4.0 million) suggests a highly profitable product. Net income turned positive at $23.0 million in Q4 2025, a sharp improvement from the $8.2 million loss in Q1 2025, and the net margin of 6.0% reflects the operational leverage in the business. However, the TTM free cash flow is negative at -$111.2 million, driven by heavy capital expenditures (capex of $94.2 million in Q4 alone) as the company invests in the Blue Creek growth project, which is expected to expand capacity and lower costs.
Quarterly Revenue
$383988000.0B
2025-12
Revenue YoY Growth
+29.1%
YoY Comparison
Gross Margin
99.0%
Latest Quarter
Free Cash Flow
$-111214999.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HCC Overvalued?
Given that net income is positive (TTM EPS of $0.0123), the PE ratio is the primary valuation metric. The trailing PE stands at 81.6x, while the forward PE is much lower at 12.3x, indicating the market expects a dramatic earnings recovery in the coming year. This wide gap suggests that the current earnings are depressed due to cyclical trough conditions, and the forward multiple reflects normalized earnings power. Compared to the industry average (not provided, but using the S&P 500's forward PE of ~20x as a proxy), HCC's forward PE of 12.3x is at a significant discount, implying the market is pricing in lower growth or higher risk. The PEG ratio is negative (-1.05) due to negative earnings growth expectations in the near term, but this is a distortion from the cyclical trough. Historically, HCC's trailing PE has ranged from as low as 1.3x in Q2 2022 to over 600x in Q4 2024, and the current 81.6x is near the higher end of that range, but this is misleading given the earnings trough; the forward PE is more indicative of the market's view.
PE
81.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 1x~23x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
18.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: HCC's negative free cash flow of -$111.2M TTM is a major concern, driven by heavy capex for Blue Creek. While the company has low debt (D/E 0.13) and a strong current ratio (3.19), sustained cash burn could deplete reserves if coal prices fall. Revenue concentration in met coal makes earnings highly volatile, as seen in the swing from a Q1 loss to Q4 profit. The high gross margin in Q4 (98.9%) is partly due to accounting adjustments, and normalized margins are more moderate, indicating potential for margin compression if costs rise.
FAQ
The primary risks are: 1) Commodity price risk - met coal prices can fall sharply, as seen in 2025, impacting revenue and margins. 2) Execution risk on Blue Creek - cost overruns or delays could strain finances. 3) Financial risk - negative FCF of -$111M could lead to liquidity issues if prices stay low. 4) Macro risk - a global recession would reduce steel demand. The most severe risk is a prolonged price downturn, which could push the stock to the 52-week low of $54.66.
Analysts have a 12-month average target of $103, with a range of $90 to $123. The base case (50% probability) sees the stock trading between $95 and $110, assuming stable coal prices and successful Blue Creek execution. The bull case (30%) targets $110-$123 on stronger prices and faster growth, while the bear case (20%) sees $70-$90 if prices decline. The most likely scenario is the base case, with the stock appreciating modestly from current levels.
HCC's trailing PE of 81.6x is high due to depressed earnings, but the forward PE of 12.3x suggests the market expects a strong recovery. Compared to the S&P 500's forward PE of ~20x, HCC is undervalued on a forward basis. The PS ratio of 3.54x is also reasonable for a commodity producer. Overall, the stock is fairly valued to slightly undervalued, assuming the earnings recovery materializes.
HCC is a good buy for investors who believe in a cyclical recovery in met coal. The stock offers 14.9% upside to the average analyst target of $103, and the forward PE of 12.3x is attractive. However, the negative FCF and commodity price risk mean it's not suitable for risk-averse investors. A good entry point would be near the 52-week low of $54.66, but at $89.62, the risk/reward is still favorable if coal prices hold.
HCC is better suited for medium-to-long-term investment (3-5 years) due to its cyclical nature and the multi-year Blue Creek project. Short-term trading is possible given the stock's volatility (beta 0.645, but price swings are large), but it's risky. Long-term investors can benefit from the expected earnings growth as Blue Creek ramps up, but they must tolerate significant price fluctuations. A minimum holding period of 3 years is recommended to ride out commodity cycles.